Amundi
XENE icon

Amundi’s Xenon Pharmaceuticals XENE Stock Holding History

Amundi’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.05M Buy
18,013
+13,404
+291% +$618K ﹤0.01% 1274
2025
Q4 		$207K Buy
+4,609
New +$194K ﹤0.01% 1757
2025
Q2 		– Sell
-114
Closed -$3.5K – 2204
2025
Q1 		$3.5K Buy
114
+25
+28% +$949 ﹤0.01% 1934
2024
Q4 		$3.52K Buy
+89
New +$3.68K ﹤0.01% 1957
2022
Q4 		– Sell
-3,581
Closed -$133K – 1989
2022
Q3 		$133K Hold
3,581
– – ﹤0.01% 1515
2022
Q2 		$115K Sell
3,581
-745
-17% -$22.5K ﹤0.01% 1425
2022
Q1 		$148K Sell
4,326
-202
-4% -$6.05K ﹤0.01% 1420
2021
Q4 		$132K Buy
+4,528
New +$135K ﹤0.01% 1536

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Amundi's XENE Position: Q1 2026 in Review

Amundi increased its Xenon Pharmaceuticals (XENE) stake by 291% in Q1 2026, buying an estimated $618K and bringing the position to 18,013 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1274.

Amundi first reported a position in XENE in Q4 2021 and has held it in 8 quarters since. 290 funds tracked by Wall St. Rank hold XENE as of Q1 2026.

  • Amundi held 18,013 shares of Xenon Pharmaceuticals worth $1.05M as of Q1 2026.
  • Amundi bought 13,404 Xenon Pharmaceuticals shares in Q1 2026, an estimated $618K.
  • Xenon Pharmaceuticals made up ﹤0.01% of Amundi's portfolio in Q1 2026, its #1274 holding.
  • Amundi first reported a position in Xenon Pharmaceuticals in Q4 2021 and has held it in 8 quarters since.
  • 290 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.